MSAM
DTIL icon

Moloney Securities Asset Management’s Precision BioSciences DTIL Stock Holding History

Moloney Securities Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-42,866
Closed -$204K – 504
2025
Q1 		$204K Sell
42,866
-44,933
-51% -$229K 0.03% 431
2024
Q4 		$335K Buy
87,799
+56,100
+177% +$410K 0.04% 328
2024
Q3 		$284K Sell
31,699
-17,500
-36% -$168K 0.04% 371
2024
Q2 		$479K Sell
49,199
-5,000
-9% -$58.9K 0.07% 275
2024
Q1 		$735K Buy
54,199
+24,524
+83% +$300K 0.11% 206
2023
Q4 		$325K Buy
29,675
+8,292
+39% +$89.4K 0.05% 325
2023
Q3 		$219K Buy
21,383
+10,983
+106% +$169K 0.04% 366
2023
Q2 		$164K Sell
10,400
-6,967
-40% -$159K 0.03% 384
2023
Q1 		$393K Sell
17,367
-2,216
-11% -$73K 0.07% 267
2022
Q4 		$699K Sell
19,583
-1,500
-7% -$59.3K 0.15% 179
2022
Q3 		$822K Buy
21,083
+3,110
+17% +$148K 0.2% 137
2022
Q2 		$863K Buy
17,973
+2,433
+16% +$143K 0.2% 135
2022
Q1 		$1.44M Buy
15,540
+3,301
+27% +$448K 0.28% 102
2021
Q4 		$2.72M Sell
12,239
-265
-2% -$74K 0.46% 49
2021
Q3 		$4.33M Buy
12,504
+433
+4% +$147K 0.79% 27
2021
Q2 		$4.53M Sell
12,071
-1,710
-12% -$514K 0.83% 24
2021
Q1 		$4.28M Buy
13,781
+2,381
+21% +$834K 0.84% 28
2020
Q4 		$2.85M Buy
11,400
+3,383
+42% +$829K 0.63% 41
2020
Q3 		$1.48M Buy
8,017
+2,799
+54% +$557K 0.39% 79
2020
Q2 		$1.3M Buy
5,218
+1,485
+40% +$325K 0.38% 86
2020
Q1 		$675K Buy
3,733
+2,761
+284% +$723K 0.24% 112
2019
Q4 		$405K Buy
+972
New +$305K 0.13% 201

Other funds holding DTIL

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Moloney Securities Asset Management's DTIL Position: Q2 2025 in Review

Moloney Securities Asset Management sold out of Precision BioSciences (DTIL) in Q2 2025, closing a stake of 42,866 shares — an estimated $204K sold.

Moloney Securities Asset Management first reported a position in DTIL in Q4 2019 and held it in 22 quarters. The position peaked at $4.53M in Q2 2021. 52 funds tracked by Wall St. Rank hold DTIL as of Q2 2025.

  • Moloney Securities Asset Management reported no remaining Precision BioSciences position as of Q2 2025 after selling out during the quarter.
  • Moloney Securities Asset Management sold 42,866 Precision BioSciences shares in Q2 2025, an estimated $204K.
  • Moloney Securities Asset Management first reported a position in Precision BioSciences in Q4 2019 and held it in 22 quarters.
  • Moloney Securities Asset Management's Precision BioSciences position peaked at $4.53M in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2025.

Based on Moloney Securities Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.